PHARMARESEARCH BIO Co., Ltd. (XKON:217950)

South Korea flag South Korea · Delayed Price · Currency is KRW
35,850
+350 (0.99%)
At close: Jul 7, 2025, 3:30 PM KST
35.54%
Market Cap 143.87B
Revenue (ttm) 178.19M
Net Income (ttm) -883.52M
Shares Out 4.05M
EPS (ttm) -22,088.06
PE Ratio n/a
Forward PE n/a
Dividend n/a
Ex-Dividend Date n/a
Volume 742
Average Volume 4,232
Open 36,000
Previous Close 35,500
Day's Range 35,600 - 36,650
52-Week Range 23,750 - 50,000
Beta 0.24
RSI 31.54
Earnings Date n/a

About PHARMARESEARCH BIO

PharmaResearch BIO Co., Ltd. engages in the research and development, manufacture, and sale of pharmaceutical products worldwide. The company offers ReNTox injection for temporary improvement in the appearance of moderate to severe glabellar lines associated with corrugator and/or procerus muscle activity in adult patients aged between 18 and 65. It is also developing Clostridium Botulinum Toxin type A, which is in Phase I clinical study for indications, including dynamic equinus foot deformity, upper limb spasticity, blepharospasm, etc. The co... [Read more]

Industry Pharmaceutical Preparations
Founded 2009
Country South Korea
Stock Exchange Korea New Exchange
Ticker Symbol 217950
Full Company Profile

Financial Performance

Financial Statements

News

There is no news available yet.